Revenue - BioNote Inc (KRX:377740) - Alpha Spread
B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 595 KRW 0.33% Market Closed
Market Cap: 468.1B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNote Inc
Revenue Peer Comparison

Comparables:
068270
302440
H
145020
P
214450
196170

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Revenue
â‚©90.1B
CAGR 3-Years
-48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Revenue
â‚©2.7T
CAGR 3-Years
11%
CAGR 5-Years
23%
CAGR 10-Years
23%
SK Bioscience Co Ltd
KRX:302440
Revenue
â‚©369.5B
CAGR 3-Years
18%
CAGR 5-Years
30%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Revenue
â‚©343.5B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Revenue
â‚©296.6B
CAGR 3-Years
30%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Revenue
â‚©90.8B
CAGR 3-Years
34%
CAGR 5-Years
42%
CAGR 10-Years
N/A

See Also

What is BioNote Inc's Revenue?
Revenue
90.1B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Revenue amounts to 90.1B KRW.

What is BioNote Inc's Revenue growth rate?
Revenue CAGR 3Y
-48%

Over the last year, the Revenue growth was -81%. The average annual Revenue growth rates for BioNote Inc have been -48% over the past three years .

Back to Top